| Multicenter Clinical Trial of ST-02 for Ablation of Upper Tract Urothelial Carcinoma (NCT06124976) | Peter Black | 2024-06-19 |
| Efficacy and Safety of UGN-101 in Recurrent Patients (NCT04006691) | UroGen Pharma Ltd. | 2019-10-01 |
| Carboplatin and Gemcitabine Hydrochloride With or Without Vandetanib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Urinary Tract Cancer (NCT01191892) | Cardiff University | 2010-06-01 |
| Pazopanib Hydrochloride in Treating Patients With Metastatic Urethral Cancer or Bladder Cancer That Has Relapsed or Not Responded to Treatment (NCT01031875) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2009-12-01 |
| Gemcitabine Hydrochloride, Cisplatin, and Sunitinib Malate as First-Line Therapy in Treating Patients With Locally Advanced And/or Metastatic Transitional Cell Carcinoma of the Urothelium (SUCCINCT) (NCT01089088) | Cardiff University | 2009-04-01 |
| Sunitinib as Second-Line Therapy in Treating Patients With Locally Advanced or Metastatic Transitional Cell Cancer (NCT00792025) | Institut Curie | 2008-12-01 |
| Gemcitabine Hydrochloride, Cisplatin, and Temsirolimus as First-Line Therapy in Treating Patients With Locally Advanced and/or Metastatic Transitional Cell Cancer of the Urothelium (NCT01090466) | Cardiff University | 2008-02-01 |
| Study of Genes and Environment in Patients With Cancer in East Anglia, Trent, or West Midlands Regions of the United Kingdom (NCT00757614) | Cancer Research UK | 2008-02-01 |
| Lapatinib, Cisplatin, Gemcitabine as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Urothelial Cancer (NCT00623064) | European Organisation for Research and Treatment of Cancer - EORTC | 2007-11-01 |
| Sunitinib in Treating Patients With Progressive Metastatic Transitional Cell Cancer of the Urothelium (NCT00397488) | Memorial Sloan Kettering Cancer Center | 2006-09-01 |
| Sunitinib Malate in Treating Patients With Locally Recurrent, Locally Advanced, Unresectable, or Metastatic Urinary Tract Cancer (NCT01118039) | Hospital del Mar | 2006-07-01 |
| Biomarkers in Patients With Kidney Cancer or Cancer of the Urothelium and in Healthy Participants (NCT00900276) | Wake Forest University Health Sciences | 2006-06-01 |
| Pemetrexed Disodium and Gemcitabine in Treating Patients With Advanced Cancer of the Urothelium (NCT00053209) | Eastern Cooperative Oncology Group | 2004-08-10 |
| S0400, FR901228 in Treating Patients With Advanced Cancer of the Urothelium (NCT00087295) | SWOG Cancer Research Network | 2004-06-01 |
| Bortezomib in Treating Patients With Advanced or Metastatic Transitional Cell Cancer of the Bladder, Renal Pelvis, or Ureter (NCT00066352) | University Health Network, Toronto | 2003-09-01 |
| S0306, Irinotecan in Treating Patients With Recurrent or Refractory Advanced Transitional Cell Cancer of the Urothelium Previously Treated With Chemotherapy (NCT00066612) | SWOG Cancer Research Network | 2003-07-01 |
| S0219, Combination Chemotherapy Followed By Observation or Surgery in Patients With Stage II or Stage III Cancer of the Urothelium (NCT00045630) | SWOG Cancer Research Network | 2003-01-01 |
| Combination Chemotherapy Following Surgery in Treating Patients With Urinary Tract Cancer (NCT00028860) | Tulane University Health Sciences Center | 2001-10-01 |
| S0028, Gemcitabine and Paclitaxel in Treating Patients With Advanced or Recurrent Cancer of the Urinary Tract (NCT00022633) | SWOG Cancer Research Network | 2001-07-01 |
| Neoadjuvant Ifosfamide, Doxorubicin, Gemcitabine, and Cisplatin in Treating Patients Who Are Undergoing Radical Cystectomy for Locally Advanced Carcinoma (Cancer) of the Urothelium (NCT00080795) | M.D. Anderson Cancer Center | 2001-07-01 |
| Cisplatin Plus Gemcitabine With or Without Paclitaxel in Treating Patients With Stage IV Urinary Tract Cancer (NCT00022191) | European Organisation for Research and Treatment of Cancer - EORTC | 2001-05-01 |
| S0031, ZD 1839 in Treating Patients With Advanced Cancer of the Urinary Tract (NCT00014144) | SWOG Cancer Research Network | 2001-02-01 |
| Combination Chemotherapy in Treating Patients With Advanced Cancer of the Urothelium and Decreased Kidney Function (NCT00005644) | Eastern Cooperative Oncology Group | 2001-01-02 |
| Combination Chemotherapy in Treating Patients With Transitional Cell Cancer of the Urothelium (NCT00014274) | European Organisation for Research and Treatment of Cancer - EORTC | 2001-01-01 |
| SCH 66336 Plus Gemcitabine in Treating Patients With Advanced Cancer of the Urinary Tract (NCT00006351) | European Organisation for Research and Treatment of Cancer - EORTC | 2000-06-01 |
| Nitrocamptothecin in Treating Patients With Metastatic Cancer of the Urinary Tract (NCT00006026) | European Organisation for Research and Treatment of Cancer - EORTC | 2000-05-01 |
| R115777 in Treating Patients With Advanced Bladder Cancer (NCT00006376) | H. Lee Moffitt Cancer Center and Research Institute | 2000-03-01 |
| Docetaxel and Gemcitabine in Treating Patients With Progressive Regional or Metastatic Bladder Cancer (NCT00004223) | Eastern Cooperative Oncology Group | 2000-02-24 |
| Oxaliplatin in Treating Patients With Metastatic Bladder Cancer (NCT00004203) | University of Chicago | 2000-02-01 |
| Combination Chemotherapy Plus Filgrastim in Treating Patients With Locally Recurrent or Advanced Urothelium Cancer (NCT00005958) | Amgen | 1999-10-01 |
| Surgery Plus Combination Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Urinary Tract (NCT00006111) | UNICANCER | 1999-04-01 |
| Two-Drug Combination Chemotherapy Compared With Four-Drug Combination Chemotherapy in Treating Patients With Advanced Cancer of the Urothelium (NCT00003376) | Eastern Cooperative Oncology Group | 1998-12-03 |
| Gemcitabine, Paclitaxel, and Cisplatin in Treating Patients With Advanced Cancer of the Urothelium (NCT00310011) | Wake Forest University Health Sciences | 1998-06-01 |
| Combination Chemotherapy in Treating Patients With Advanced Bladder or Kidney Cancer (NCT00003342) | Memorial Sloan Kettering Cancer Center | 1997-12-01 |
| Fluorouracil in Treating Patients With Recurrent or Metastatic Bladder Cancer (NCT00003175) | Medical Research Council | 1997-12-01 |
| Combination Chemotherapy in Treating Patients With Metastatic or Locally Advanced Bladder Cancer (NCT00003105) | Memorial Sloan Kettering Cancer Center | 1997-09-01 |
| Combination Chemotherapy Following Surgery in Treating Patients With Advanced Bladder Cancer (NCT00003133) | Memorial Sloan Kettering Cancer Center | 1997-09-01 |
| Piritrexim in Treating Patients With Advanced Cancer of the Urinary Tract (NCT00002914) | Eastern Cooperative Oncology Group | 1997-07-15 |